Patrick Ryan Langston - Oct 15, 2024 Form 4 Insider Report for Goosehead Insurance, Inc. (GSHD)

Signature
/s/ John O'Connor, as Attorney-in-Fact for Patrick Ryan Langston
Stock symbol
GSHD
Transactions as of
Oct 15, 2024
Transactions value $
-$953,500
Form type
4
Date filed
10/16/2024, 06:08 PM
Previous filing
Oct 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GSHD Class A Common Stock Options Exercise $409K +10K +200% $40.88 15K Oct 15, 2024 Direct
transaction GSHD Class A Common Stock Sale -$954K -10K -66.67% $95.35 5K Oct 15, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GSHD Employee Stock Options (right to buy) Options Exercise -$409K -10K -16.39% $40.88 51K Oct 15, 2024 Class A Common Stock 10K $40.88 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This does not reflect shares directly held by the reporting person's spouse, who is independently a reporting person of the issuer.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F3 One third (1/3rd) of the option, which represents the right to purchase a total of 81,000 shares, vested and became exercisable, on each of the second, third, and fourth anniversaries of the grant date, which was April 1, 2020.